COMMUNIQUÉS West-GlobeNewswire

Inspire Medical Systems, Inc. to Present at the 30th Annual Piper Jaffray Healthcare Conference

14/11/2018 - 14:00

MINNEAPOLIS, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019

14/11/2018 - 14:00

Reports over $52 million of cash-on-hand with Company now fully funded beyond completion of the TRILOGY Phase 3 studies Both TRILOGY studies surpass 90% enrollment and remain on track to report topline results in 2019 [...]

Ovid Therapeutics to Present at 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27

14/11/2018 - 14:00

NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]

Gritstone Oncology Reports Third Quarter 2018 Financial Results and Recent Business Highlights

14/11/2018 - 14:00

Successful Initial Public Offering Raises $95.6 Million in Net Proceeds EMERYVILLE, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing [...]

Reflect Scientific Reports Strong Sales - Cryometrix Freezers Lead

14/11/2018 - 14:00

OREM, Utah, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (OTC:RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announces a 27% year [...]

NanoVibronix Provides Business Update for the Third Quarter of 2018

14/11/2018 - 14:00

Lays out key upcoming milestones for the next 12 months ELMSFORD, N.Y., Nov. 14, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low [...]

Entasis Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update

14/11/2018 - 14:00

Completed $75.0 million initial public offering in September Reported positive Phase 2 topline results of lead program ETX2514SUL On-track to initiate two Phase 3 clinical trials in 2019 WALTHAM, Mass., Nov. 14, 2018 ( [...]

Eidos Therapeutics to Present at Two Upcoming Investor Conferences

14/11/2018 - 14:00

SAN FRANCISCO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management will present a company overview at two upcoming investor conferences. Piper Jaffray [...]

Rexahn Pharmaceuticals Announces Leadership Transition

14/11/2018 - 14:00

Douglas Swirsky Assumes Role of Chief Executive Officer ROCKVILLE, Md., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing [...]

PotNetwork Holdings’ Diamond CBD Engages With Fellow Industry Leaders at MJBizCon

14/11/2018 - 14:00

Diamond CBD Features Latest Products at Booth 4517 , During Marijuana Business Daily’s Flagship Event at the Las Vegas Convention Center FORT LAUDERDALE, Fla., Nov. 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- [...]

Spectral Announces Third Quarter Results

14/11/2018 - 14:00

TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]

Cue Biopharma to Host Business Update Call and Webcast

14/11/2018 - 14:00

CAMBRIDGE, Mass., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human [...]

RedHill Biopharma Announces Presentation on YELIVA® (opaganib) for Multiple Myeloma at EORTC-NCI-AACR Symposium

14/11/2018 - 14:00

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Canntab Corporate Update

14/11/2018 - 13:41

TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited ( CSE: PILL , FSE: TBF1) (“Canntab” or the “Company”) is a company with a clear vision of becoming the leader in solid oral dosage formulation of [...]

MacroGenics Announces Poster Presentation on Preclinical PD-L1 x CD137 DART® Program at the EORTC-NCI-AACR Symposium in Dublin

14/11/2018 - 13:30

ROCKVILLE, MD, Nov. 14, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer

14/11/2018 - 13:25

OXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s Chief Financial Officer [...]

Iterum Reports Third Quarter 2018 Financial Results and Recent Highlights

14/11/2018 - 13:15

DUBLIN, Ireland and CHICAGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, today [...]

Aleafia Health to Launch Global Cannabis Education Platform with D2L

14/11/2018 - 13:00

Platform to Provide Cannabis Education Courses TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“ Aleafia ”) has entered into a global agreement with D2L ( [...]

Axsome Therapeutics Announces Completion of Patient Enrollment in the ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder

14/11/2018 - 13:00

NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]